ALSO READ: US man who got 1st pig heart transplant dies after 2 months "The Mass General transplant team is deeply saddened at the sudden passing of Mr. Rick Slayman. We have no indication that it was the result of his recent transplant," ABC News quoted Massachusetts General Hospital statement.
According to details, Slayman – before receiving the transplant – had battled Type 2 diabetes and hypertension for years. He also relied on dialysis for years before receiving a human kidney transplant in December 2018, which was performed by the same Massachusetts General Hospital team. However, the transplanted kidney from the human donor showed rejection signs, and he returned to dialysis treatment in 2023.
"Mr. Slayman will forever be seen as a beacon of hope to countless transplant patients worldwide and we are deeply grateful for his trust and willingness to advance the field of xenotransplantation. We offer our heartfelt condolences to Mr Slayman's family and loved ones as they remember an extraordinary person whose generosity and kindness touched all who knew him," the hospital's statement read.
ALSO READ: ICMR issues dietary guidelines for Indians, says 'avoid' protein supplements But in March, Slayman underwent another kidney transplant that arrived from eGenesis, a Cambridge-based pharmaceutical company. It was harvested from a pig genetically modified using CRISPR-Cas9 technology. Massachusetts General Hospital said that they removed incompatible pig genes and introduced specific human genes to enhance compatibility with the recipient's body, but after seven weeks, he died.
Read more on livemint.com